Bio-Rad Laboratories Inventory 2010-2025 | BIO
Bio-Rad Laboratories inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
- Bio-Rad Laboratories inventory for the quarter ending March 31, 2025 was $0.790B, a 0.86% increase year-over-year.
- Bio-Rad Laboratories inventory for 2024 was $0.76B, a 2.63% decline from 2023.
- Bio-Rad Laboratories inventory for 2023 was $0.781B, a 8.51% increase from 2022.
- Bio-Rad Laboratories inventory for 2022 was $0.719B, a 25.7% increase from 2021.
| Bio-Rad Laboratories Annual Inventory (Millions of US $) |
|
|---|---|
| 2024 | $760 |
| 2023 | $781 |
| 2022 | $719 |
| 2021 | $572 |
| 2020 | $622 |
| 2019 | $554 |
| 2018 | $584 |
| 2017 | $595 |
| 2016 | $525 |
| 2015 | $490 |
| 2014 | $471 |
| 2013 | $516 |
| 2012 | $455 |
| 2011 | $434 |
| 2010 | $398 |
| 2009 | $351 |
| Bio-Rad Laboratories Quarterly Inventory (Millions of US $) |
|
|---|---|
| 2025-03-31 | $790 |
| 2024-12-31 | $760 |
| 2024-09-30 | $804 |
| 2024-06-30 | $804 |
| 2024-03-31 | $783 |
| 2023-12-31 | $781 |
| 2023-09-30 | $776 |
| 2023-06-30 | $777 |
| 2023-03-31 | $753 |
| 2022-12-31 | $719 |
| 2022-09-30 | $686 |
| 2022-06-30 | $657 |
| 2022-03-31 | $605 |
| 2021-12-31 | $572 |
| 2021-09-30 | $589 |
| 2021-06-30 | $599 |
| 2021-03-31 | $605 |
| 2020-12-31 | $622 |
| 2020-09-30 | $640 |
| 2020-06-30 | $628 |
| 2020-03-31 | $557 |
| 2019-12-31 | $554 |
| 2019-09-30 | $588 |
| 2019-06-30 | $590 |
| 2019-03-31 | $590 |
| 2018-12-31 | $584 |
| 2018-09-30 | $601 |
| 2018-06-30 | $591 |
| 2018-03-31 | $612 |
| 2017-12-31 | $595 |
| 2017-09-30 | $602 |
| 2017-06-30 | $581 |
| 2017-03-31 | $560 |
| 2016-12-31 | $525 |
| 2016-09-30 | $556 |
| 2016-06-30 | $542 |
| 2016-03-31 | $533 |
| 2015-12-31 | $490 |
| 2015-09-30 | $513 |
| 2015-06-30 | $501 |
| 2015-03-31 | $478 |
| 2014-12-31 | $471 |
| 2014-09-30 | $516 |
| 2014-06-30 | $521 |
| 2014-03-31 | $514 |
| 2013-12-31 | $516 |
| 2013-09-30 | $524 |
| 2013-06-30 | $485 |
| 2013-03-31 | $467 |
| 2012-12-31 | $455 |
| 2012-09-30 | $458 |
| 2012-06-30 | $449 |
| 2012-03-31 | $463 |
| 2011-12-31 | $434 |
| 2011-09-30 | $446 |
| 2011-06-30 | $449 |
| 2011-03-31 | $430 |
| 2010-12-31 | $398 |
| 2010-09-30 | $403 |
| 2010-06-30 | $370 |
| 2010-03-31 | $381 |
| 2009-12-31 | $351 |
| 2009-09-30 | $384 |
| 2009-06-30 | $378 |
| 2009-03-31 | $369 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $5.968B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.034B | 28.02 |
| Boston Scientific (BSX) | United States | $152.131B | 38.08 |
| Stryker (SYK) | United States | $146.225B | 30.58 |
| EssilorLuxottica (ESLOY) | France | $128.281B | 0.00 |
| Medtronic (MDT) | Ireland | $111.581B | 15.82 |
| Haleon (HLN) | United Kingdom | $50.069B | 28.51 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.244B | 0.00 |
| ResMed (RMD) | United States | $36.611B | 27.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.762B | 15.55 |
| Agilent Technologies (A) | United States | $32.366B | 21.10 |
| Terumo (TRUMY) | Japan | $26.576B | 34.52 |
| Insulet (PODD) | United States | $22.320B | 87.61 |
| Koninklijke Philips (PHG) | Netherlands | $21.929B | 15.76 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.186B | 11.68 |
| Baxter (BAX) | United States | $15.472B | 11.55 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.270B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.449B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.558B | 14.02 |
| Prestige Consumer Healthcare (PBH) | United States | $4.181B | 18.68 |
| Perrigo (PRGO) | Ireland | $3.570B | 9.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.382B | 15.40 |
| ICU Medical (ICUI) | United States | $3.271B | 24.12 |
| Envista Holdings (NVST) | United States | $3.166B | 26.31 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.022B | 13.91 |
| LeMaitre Vascular (LMAT) | United States | $1.884B | 42.12 |
| AtriCure (ATRC) | United States | $1.726B | 0.00 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.080B | 24.29 |
| Neogen (NEOG) | United States | $1.066B | 13.64 |
| Kestra Medical Technologies (KMTS) | United States | $1.025B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.38 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.633B | 0.00 |
| Evolus (EOLS) | United States | $0.628B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.602B | 0.00 |
| Owens & Minor (OMI) | United States | $0.588B | 4.88 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.553B | 0.00 |
| Valneva SE (VALN) | France | $0.525B | 0.00 |
| Surmodics (SRDX) | United States | $0.426B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.391B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.345B | 12.68 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 54.10 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.264B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.97 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.254B | 11.54 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.238B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.210B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.202B | 0.00 |
| Biote (BTMD) | United States | $0.201B | 5.65 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Brainsway (BWAY) | Israel | $0.195B | 51.55 |
| Omeros (OMER) | United States | $0.193B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.127B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| Agape ATP (ATPC) | $0.073B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.036B | 48.57 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |